Oncosil Medical Ltd (OSL) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.814x

Based on the latest financial reports, Oncosil Medical Ltd (OSL) has a cash flow conversion efficiency ratio of -1.814x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-6.96 Million ≈ $-4.93 Million USD) by net assets (AU$3.84 Million ≈ $2.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Oncosil Medical Ltd market capitalisation for the company's overall valuation and market capitalisation.

Oncosil Medical Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Oncosil Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Oncosil Medical Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncosil Medical Ltd ranked by their cash flow conversion efficiency. See OSL debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Iz Hayvancilik Tarim ve Gida Sanayi Ticaret AS IS:IZINV	-0.336x
HYUNGJI INNOVATION & CREATIVE Co.Ltd KQ:011080	-0.071x
NPK Co.Ltd KQ:048830	0.058x
Cardiex Ltd AU:CDX	-0.452x
Neungyule Education Inc KQ:053290	0.065x
Asuransi Jasa Tania Tbk JK:ASJT	0.043x
Korea Plasma Technology U Co.Ltd KQ:054410	0.004x
GENOMTEC S.A. ZY -10 F:4VI	N/A

Annual Cash Flow Conversion Efficiency for Oncosil Medical Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Oncosil Medical Ltd from 2005 to 2025. View Oncosil Medical Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$3.10 Million ≈ $2.20 Million	AU$-12.06 Million ≈ $-8.53 Million	-3.887x	-70.07%
2024-06-30	AU$4.74 Million ≈ $3.35 Million	AU$-10.82 Million ≈ $-7.66 Million	-2.285x	-99.55%
2023-06-30	AU$9.88 Million ≈ $6.99 Million	AU$-11.32 Million ≈ $-8.01 Million	-1.145x	-26.45%
2022-06-30	AU$11.16 Million ≈ $7.90 Million	AU$-10.11 Million ≈ $-7.15 Million	-0.906x	-20.17%
2021-06-30	AU$11.70 Million ≈ $8.28 Million	AU$-8.82 Million ≈ $-6.24 Million	-0.754x	-270.43%
2020-06-30	AU$21.90 Million ≈ $15.50 Million	AU$-4.46 Million ≈ $-3.15 Million	-0.203x	+71.04%
2019-06-30	AU$10.68 Million ≈ $7.55 Million	AU$-7.50 Million ≈ $-5.31 Million	-0.703x	-51.92%
2018-06-30	AU$18.15 Million ≈ $12.85 Million	AU$-8.40 Million ≈ $-5.94 Million	-0.463x	+23.27%
2017-06-30	AU$10.13 Million ≈ $7.17 Million	AU$-6.11 Million ≈ $-4.32 Million	-0.603x	-95.27%
2016-06-30	AU$14.81 Million ≈ $10.48 Million	AU$-4.57 Million ≈ $-3.24 Million	-0.309x	-1155.70%
2015-06-30	AU$6.96 Million ≈ $4.93 Million	AU$-171.16K ≈ $-121.11K	-0.025x	+96.33%
2014-06-30	AU$9.52 Million ≈ $6.73 Million	AU$-6.37 Million ≈ $-4.51 Million	-0.669x	-758.32%
2013-06-30	AU$6.05 Million ≈ $4.28 Million	AU$-471.91K ≈ $-333.90K	-0.078x	+36.67%
2012-06-30	AU$2.48 Million ≈ $1.76 Million	AU$-305.78K ≈ $-216.36K	-0.123x	-13.30%
2011-06-30	AU$2.91 Million ≈ $2.06 Million	AU$-316.67K ≈ $-224.06K	-0.109x	-281.54%
2010-06-30	AU$2.58 Million ≈ $1.82 Million	AU$154.35K ≈ $109.21K	0.060x	+346.60%
2009-06-30	AU$4.28 Million ≈ $3.03 Million	AU$-103.97K ≈ $-73.57K	-0.024x	+95.45%
2008-06-30	AU$4.09 Million ≈ $2.89 Million	AU$-2.18 Million ≈ $-1.54 Million	-0.533x	-85.54%
2007-06-30	AU$4.68 Million ≈ $3.31 Million	AU$-1.35 Million ≈ $-952.00K	-0.288x	-902.55%
2006-06-30	AU$5.46 Million ≈ $3.86 Million	AU$195.51K ≈ $138.34K	0.036x	+278.21%
2005-06-30	AU$899.56K ≈ $636.50K	AU$-18.08K ≈ $-12.80K	-0.020x	--

About Oncosil Medical Ltd

AU:OSL Australia Medical Devices

Market Cap

$15.71 Million

AU$22.20 Million AUD

Market Cap Rank

#26441 Global

#1204 in Australia

Share Price

AU$0.94

Change (1 day)

+1.62%

52-Week Range

AU$0.39 - AU$1.77

All Time High

AU$1.99